Minozzi et al.
JOCArticle
(314): 337 (M þ Naþ). HRMS (ESI/Q-TOF): calcd m/z for
0.26 mmol), 2,2-dimethoxy-2-phenyl-acetophenone (7 mg,
0.026 mmol), and DMF (1.5 mL) was irradiated at room tempera-
ture for 1 h under magnetic stirring, and then concentrated. The
resulting residue was eluted from a column of silica gel with (i-Pr)2O
and then with 9:1 (i-Pr)2O/AcOEt to give 17 (179 mg, 88%) as 1.5:1
C14H18NaO4S2 [M þ Na]þ, 337.0544; found, 337.0548.
Methyl 2-(1-[(2-Methoxy-2-oxoethyl)sulfanyl]-2-phenylethyl-
sulfanyl)acetate (9). Column chromatography with 5:1 hexanes-
AcOEt afforded 9 as a yellow oil. GC-MS: r.t. 11.80, m/z 314 (Mþ,
<1), 241 (27), 223 (50), 209 (26), 177 (48), 149 (100), 135 (50),
115(38), 103(14), 91(51). 1HNMR(400 MHz):δ=7.35-7.22(m,
5 H, Ph), 4.38 (t, 1 H, J1,2 = 7.1 Hz, H-1), 3.70 (s, 6 H, OMe), 3.45
1
mixture of E and Z isomers. H NMR (300 MHz, DMSO-d6,
120 °C, mixture of E and Z isomers): δ = 7.86 (d, 2 H, J = 7.4 Hz,
Ar), 7.68 (d, 2 H, J = 7.4 Hz, Ar), 7.46-7.39 and 7.38-7.30 (2 m,
and 3.22 (2 d, 4 H, J = 15.2 Hz, 2 CH2CO), 3.13 (d, 2 H, 2H-2). 13
C
4 H, Ar), 7.14 (bs, 1 H, NH), 6.360(ddd, 0.6 H, J1 ,3a = 0.5 Hz,
0
0
0
J1 ,3b =0.6Hz, J1 ,2 = 15.0 Hz, H-1 (E)), 6.32(ddd, 0.4H, J1 ,3a
0
0
0
0
0
NMR (100 MHz): δ = 170.6 (2C), 137.5, 129.3 (2C), 128.4 (2C),
127.0, 53.8, 52.4 (2C), 42.2, 32.4 (2C). ESI MS (314): 337 (M þ
Naþ). HRMS (ESI/Q-TOF): calcd m/z for C14H18NaO4S2 [M þ
Na]þ, 337.0544; found, 337.0549.
=
0
0
0
0
0
0.5 Hz, J1 ,3b =0.6Hz,J1 ,2 =9.5Hz,H-1 (Z)),5.75-5.60 (m, 1 H,
H-20), 5.28-5.15 (m, 1 H, H-300), 4.94 (dd, 0.4 H, J3 ,4 = 9.0 Hz,
00 00
00
00 00
00 00
00 00
J4 ,5 = 9.5 Hz, H-4 (Z)), 4.92 (dd, 0.6 H, J3 ,4 = 9.0 Hz, J4 ,5
=
(2R,E/Z)-Methyl 2-Acetamido-3-(oct-1-enylthio)propanoate
(11). Column chromatography with 2:1 hexanes-AcOEt afforded
11 as a 1.5:1 mixture of Zand Eisomers. GC-MS: Z-11, r.t. 9.41, m/
z287 (Mþ,1),228(22),177(8),144(16),111(13),87(26),81(11),69
(38), 55 (32), 43 (100); E-11, r.t. 9.56, m/z 287 (Mþ, 2), 228 (18), 177
(5), 144 (14), 111 (13), 87 (14), 81 (15), 69 (33), 55 (34), 43 (100). 1H
NMR(400 MHz): δ = 6.33 (bd, 1 H, J = 7.0 Hz, NH), 5.90-5.70
9.5 Hz, H-400(Z)), 4.85-4.70 (m, 1 H, H-100, H-200), 4.40-4.32 (m,
2 H, FmocCH2), 4.30-4.06 and 4.00-3.88 (2 m, 7 H, FmocCH,
H-2, 2 H-30, H-500, 2 H-600), 3.20-2.80 (m, 2 H, 2 H-3), 2.05-1.92
(8 s, 12 H, CH3), 1.45 (s, 9 H, t-Bu). 13C NMR (75 MHz, mixture of
E and Z isomers and conformers, selected data): δ = 170.3, 169.3,
115.6, 143.8, 141.3,128.5, 127.7, 125.1, 123.7, 120.0, 99.2, 83.2, 72.8,
71.7, 713, 69.3, 68.4, 67.2, 65.5, 61.9, 54.8, 54.1, 47.1, 37.0, 35.2, 27.9,
20.7. ESI MS (785): 803 (M þ NH4þ). HRMS (ESI/Q-TOF): calcd
m/z for C39H51N2O14S [M þ NH4]þ, 803.3050; found, 803.3061.
(2R,20R/S,200R)-tert-Butyl 2-(((9H-Fluoren-9-yl)methoxy)car-
bonylamino)-3-(10-(200-((9H-fluoren-9-yl)methoxy)carbonylamino)-
300-tert-butoxy-300-oxopropylthio)-30-((2000,3000,4000,6000-tetra-O-acetyl-
β-D-glucopyranosyl)oxypropan-20-ylthio)propanoate (18). To a
mixture of cysteine derivative 16 (155 mg, 0.39 mmol), propar-
gyl glycoside 15 (75 mg, 0.20 mmol), and 2,2-dimethoxy-2-phenyl-
acetophenone (10 mg, 0.039 mmol) in toluene (2 mL) was added
H2O (19 mL). The resulting dispersion was irradiated at room
temperature for 2 h under vigorous magnetic stirring, then concen-
trated, and eluted from a column of silica gel with (i-Pr)2O and then
with 9:1 (i-Pr)2O/AcOEt to give 18 (206 mg, 85%) as a ∼1:1 mixture
of C20-diastereoisomers. 1H NMR (300 MHz, DMSO-d6, 120 °C,
mixture of diastereoisomers): δ=7.86(d, 4H, J= 7.4 Hz, Ar), 7.68
(d, 4 H, J = 7.4 Hz, Ar), 7.45-7.36 and 7.35-7.28 (2 m, 8 H, Ar),
(m, 1.4 H, H-10(E), H-10(Z), H-20(E)), 5.58 (ddd, 0.6 H, J2 ,3a
0
0
=
0
0
0
0
0
7.2 Hz, J2 ,3 b = 7.3 Hz, J1 ,2 = 9.3 Hz, H-2 (Z), 4.91-4.83 (m, 1 H,
H-2), 3.75 (s, 3 H, OMe), 3.23-3.04 (m, 2 H, 2H-3), 2.17-2.00 (m,
2 H, 2H-30), 1.42-1.20 and 0.98-0.84 (2 m, 11 H, 2H-40, 2H-50,
2-H60, 2H-70, 3-H80). 13C NMR (100 MHz, selected data): δ =
170.8, 169.7, 134.2, 131.4, 123.8, 121.5, 52.6, 52.5, 52.1, 36.0, 35.3,
33.1, 31.6, 31.5, 29.0, 28.9, 28.8, 28.7, 23.1, 22.6, 22.5, 14.0. ESI MS
(287): 310 (M þ Naþ). HRMS (ESI/Q-TOF): calcd m/z for
C14H25NNaO3S [M þ Na]þ, 310.1453; found, 310.1457.
Dimethyl (4R,11R)-7-Hexyl-2,13-dioxo-6,9-dithia-3,12-dia-
zatetradecane-4,11-dicarboxylate (12). Column chromatography
with 1:2 hexanes-AcOEt afforded 12 as a 1:1 mixture of C2
diastereoisomers. GC-MS: r.t. ∼25 (very broad peak), m/z 320
(Mþ-N-Ac-Cys, 2%), 288 (18), 287 (13), 246 (14), 232 (17), 228
(28), 176 (34), 144 (9), 43 (100). 1H NMR (400 MHz): δ = 6.64 (t,
1 H, J = 7.2 Hz, NH), 6.54 (t, 1 H, J = 7.9 Hz, NH), 4.89-4.79 (m,
2H, H-20, H-200), 3.78 (s, 6H, OMe), 3.10-2.91 and 2.84-2.65 (2 m,
7 H, 2H-1, H-2, 2H-30, 2H-300), 2.07 and 2.06 (2 s, 6 H, C(O)Me),
1.78-1.60, 1.52-1.40, and 1.39-1.20 (3 m, 10 H, 2H-3, 2H-4, 2H-5,
2H-6, 2H-7), 0.88(t, 3 H, J = 6.7 Hz, 3H-8). 13C NMR (100 MHz,
selected data): δ = 171.3, 171.2 (2C), 170.0, 169.9, 52.7, 52.6, 52.3,
52.1, 52.0, 46.0, 38.7 (2C), 35.1, 35.0, 34.0, 33.9, 32.9, 32.7, 31.6, 29.0,
26.7, 26.6, 23.0, 22.5, 14.0. ESI MS (464): 487 (M þ Naþ). HRMS
(ESI/Q-TOF): calcd m/z for C20H36N2NaO6S2 [M þ Na]þ,
487.1912; found, 487.1921.
000,4000
000,3000
= 9.0 Hz, J2
7.06 (bs, 2 H, NH), 5.22 (dd, 0.5 H, J3
=
=
9.5 Hz, H-3000(diast. I)), 5.20 (dd, 0.5 H, J3
000,4000
000,3000
= 9.0 Hz, J2
9.5 Hz, H-3000(diast. II)), 4.93 (dd, 0.5 H, J4
= 9.0 Hz, H-4000-
000,5000
000,5000
(diast. I)), 4.92 (dd, 0.5 H, J4
= 9.0 Hz, H-4000(diast. II)),
4.86-4.74 (m, 2 H, H-1000, H-2000), 4.44-3.89 (m, 12 H, 2 FmocCH,
2 FmocCH2, H-2, H-200, H-30a, H-5000, 2 H-6000), 3.82 (dd, 0.5 H,
J
J
2 ,3 b = 5.0 Hz, J3 a,3 b = 10.5 Hz, H-30b (diast. I), 3.70 (dd, 0.5 H,
0 0 0 0
2 ,3 b = 5.5 Hz, J3 a,3 b = 10.5 Hz, H-30b (diast. II), 3.20-2.70 (m,
0
0
0
0
5 H, 2 H-3, 2 H-100, H-20), 2.02-1.92 (8 s, 12 H, CH3), 1.46-1.42
(4 s, 18 H, t-Bu). 13C NMR (75 MHz, mixture of diastereoisomers
and conformers, selected data):δ= 170.6, 169.4, 155.8, 143.8, 141.3,
127.7, 127.0, 125.1, 120.0, 101.2, 100.8, 83.0, 82.9, 72.7, 72.6, 71.8,
71.0, 68.3, 67.2, 61.8, 54.6, 53.4, 47.0, 34.4, 28.0, 20.7, 20.6. ESI MS
(1184): 1203 (M þ NH4þ). HRMS (ESI/Q-TOF): calcd m/z for
C61H76N3O18S2 [M þ NH4]þ, 1202.4560; found, 1202.4551.
(2R,E/Z) Methyl 2-Acetamido-3-(styrylthio)propanoate (14).
Column chromatography with AcOEt afforded 14 as a ∼1:1
mixture of E and Z isomers (reported NMR spectra are for a 4:1
Z/E mixture). GC-MS: Z-14, r.t. 10.27, m/z 279 (Mþ, 14), 220
(45), 161 (23), 144 (63), 134 (43), 116 (28), 115 (54), 98 (72), 91
(46), 84 (17), 77 (23), 43 (100); E-14, r.t. 10.52, m/z 279 (Mþ, 14),
220 (49), 161 (25), 144 (62), 134 (47), 116 (28), 115 (61), 98 (74),
(2R,20R/S,200R)-Methyl 2-((tert-Butoxycarbonylamino)-3-(10-
(200-((9H-fluoren-9-yl)methoxy)carbonylamino)-300-tert-butoxy-
300-oxopropylthio)-30-(2000,3000,4000,6000-tetra-O-acetyl-β-D-gluco-
pyranosyl)oxypropan-20-ylthio)propanoate (20). To a mixture of
alkene 17 (150 mg, 0.19 mmol), cysteine derivative 19 (90 mg, 0.38
mmol), 2,2-dimethoxy-2-phenyl-acetophenone (10 mg, 0.038 mmol)
in toluene (2.0 mL) was added H2O (19 mL). The resulting
dispersion was irradiated at room temperature for 2 h under
magnetic stirring, and then concentrated. The resulting residue was
eluted from a column of silica gel with 8:1 (i-Pr)2O/AcOEt to give 20
(146 mg, 75%) as a ∼1:1 mixture of C20-diastereoisomers. 1H NMR
(300 MHz, DMSO-d6, 120 °C, mixture of diastereoisomers): δ =
7.86 (d, 2 H, J = 7.4 Hz, Ar), 7.70 (d, 2 H, J = 7.4 Hz, Ar),
7.45-7.38 and 7.37-7.30 (2 m, 4 H, Ar), 7.14 (bs, 1 H, NH), 6.60
1
91 (51), 84 (17), 77 (25), 43 (100). H NMR (400 MHz): δ =
0
0
7.46-7.16 (m, 5 H, Ph), 6.64 and 6.56 (2 d, 1 H, J1 ,2 = 15.6 Hz,
H-10(E), H-20(E), 6.42 and 6.12 (2 d, 1 H, J1 ,2 = 10.7 Hz,
H-10(Z), H-20(Z), 6.38 (d, 1 H, J = 7.1 Hz, NH), 4.97-4.88 (m,
1 H, H-2), 3.77 (s, 1.5 H, OMe), 3.72 (s, 1.5 H, OMe), 3.38-3.21
(m, 2 H, 2H-3), 2.03 (s, 3 H, C(O)Me), 2.00 (s, 3 H, C(O)Me). 13C
NMR (100 MHz, selected data): δ = 171.0 (E), 170.7 (Z), 170.5
(E), 169.8 (Z), 136.3, 129.4, 128.6, 128.5, 128.1, 127.3, 126.9,
126.5, 126.2, 125.5, 123.7, 60.3, 52.6, 52.4, 52.2, 37.7, 35.0, 22.9,
20.9, 14.0. ESI MS (279): 302 (M þ Naþ). HRMS (ESI/Q-TOF):
calcd m/z for C14H17NNaO3S [M þ Na]þ, 302.0827; found,
302.0830.
0
0
(2R,E/Z)-tert-Butyl 2-(((9H-Fluoren-9-yl)methoxy)carbonyl-
amino)-3-(30-(200,300,400,600-tetra-O-acetyl-β-D-glucopyranosyl)-
oxyprop-1-enylthio)propanoate (17). A mixture of propargyl glyco-
side 15 (300 mg, 0.78 mmol), cysteine derivative 16 (103 mg,
000,4000
000,3000
= 9.5 Hz,
(bs, 1 H, NH), 5.35 (dd, 0.5 H, J3
= 9.0 Hz, J2
H-3000(diast. I)), 5.90(d, 0.5H,J1
=7.5Hz, H-1000 (diast. I),5.24
= 9.5 Hz, H-3000(diast. II)),
000,2000
000,4000
(dd, 0.5 H, J3
000,3000
= 9.0 Hz, J2
458 J. Org. Chem. Vol. 76, No. 2, 2011